GSK Pharma Q1 profit at Rs 88.59 crore
New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) reported a standalone net profit of Rs 88.59 crore for the first quarter of the current fiscal.
It had posted a net profit of Rs 26.42 crore for April-June quarter of last fiscal, 2017-18, GlaxoSmithKline said in a filing to BSE.
The company's standalone total income was Rs 753.43 crore for the first quarter of 2018-19. It was Rs 620.84 crore for the year-ago period.
It said the figures for the quarter ended June 30, 2018-19, are not comparable with the corresponding quarter of last fiscal.
The board has approved and recommended a bonus issue of one equity share for every equity share held as on a record date to be determined, GlaxoSmithKline said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd